Beta2-adrenergic activation via administration of atenolol/formoterol combination increases contractility and coronary blood flow in isolated rat hearts.

Watson, Dionysios C; Sargianou, Maria; Leivaditis, Vassilios; Anagnostopoulos, Constantinos

Watson, Dionysios C; Sargianou, Maria; Leivaditis, Vassilios; Anagnostopoulos, Constantinos.

Affiliation

Watson DC; Department of Medicine, University of Patras, Greece.

Hellenic J Cardiol ; 54(5): 341-7, 2013.

Article in En | MEDLINE | ID: mdl-24100176

Subject(s)

Adrenergic beta-1 Receptor Antagonists/administration & dosage; Adrenergic beta-2 Receptor Agonists/administration & dosage; Atenolol/administration & dosage; Coronary Circulation/physiology; Ethanolamines/administration & dosage; Heart/drug effects; Myocardial Contraction/physiology; Receptors, Adrenergic, beta-2/metabolism; Animals; Coronary Circulation/drug effects; Drug Therapy, Combination; Female; Formoterol Fumarate; Heart Rate/drug effects; In Vitro Techniques; Myocardial Contraction/drug effects; Rats; Rats, Wistar

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Atenolol / Receptors, Adrenergic, beta-2 / Coronary Circulation / Ethanolamines / Adrenergic beta-2 Receptor Agonists / Adrenergic beta-1 Receptor Antagonists / Heart / Myocardial Contraction Limits: Animals Language: En Journal: Hellenic J Cardiol Journal subject: CARDIOLOGIA Year: 2013 Type: Article Affiliation country: Greece

Search on Google

XML

PubMed Links